Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1401 - 1425 of 3607 in total
Metamizole (dipyrone) is a pyrazolone derivative that belongs to the group of nonacid nonopioids. It is considered a potent analgesic and antipyretic with favourable gastrointestinal tolerability. Metamizole was formerly marketed in the US as Dimethone tablets and injection, Protemp oral liquid, and other drug products, and was withdrawn due to...
Approved
Investigational
Withdrawn
Matched Products: … DEVALJİN TABLET, 10 TABLET ... SEBON 1 G AMPUL, 10 ADET ... NOVALGIN 1G/2 ML 10 AMPUL …
Etravirine is an antiretroviral agent more specifically classified as a Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI). Etraverine is used clinically for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. On January 18, 2007, the FDA granted accelerated approved for the use of etravirine 100mg tablets in the treatment of...
Approved
Venetoclax is a BCL-2 inhibitor that was initially approved by the FDA in April 2016 [FDA label]. Proteins in the B cell CLL/lymphoma 2 (BCL-2) family are important regulators of the apoptotic (programmed cell death) process , . Venetoclax is used to treat chronic lymphocytic leukemia (CLL) and certain types...
Approved
Investigational
Matched Description: … Venetoclax is approximately 10 times more potent than navitoclax with regard to induction of apoptosis …
Matched Products: … VENCLYXTO 10 MG FILM KAPLI TABLET, 10 ADET ... เว็นเคล็กซ์ต้า 10 มิลลิกรัม ... VENCLYXTO 10 MG FILM KAPLI TABLET, 14 ADET …
Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone. It forms colorless crystals that are readily soluble in most organic solvents. It is used as an ingredient in sunscreen and other cosmetics because it absorbs UV-A ultraviolet rays.
Approved
Investigational
Matched Mixtures name: … Givenchy Photo Perfexion Evanescent Fluid Fondation SPF 10 Light Amber 8 ... Sb 10 SPF 30 ... Hand Cream SPF 10
Mavacamten is a myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM). It received initial US FDA approval in 2022, and it is one of the first myosin inhibitors to be used in humans. Mavacamten was also approved...
Approved
Investigational
The structure of adenosine was first described in 1931, though the vasodilating effects were not described in literature until the 1940s. Adenosine is indicated as an adjunct to thallium-201 in myocardial perfusion scintigraphy, though it is rarely used in this indication, having largely been replaced by dipyridamole and [regadenson].[A229833,A229838] Adenosine...
Approved
Investigational
Matched Mixtures name: … Return 10 Recovery Balm ... Return 10 TIME LOCK PROGRAM ... Return 10 TIME LOCK PROGRAM …
Matched Products: … ICEREN 10 ML 10 FLAKON ... Tissen NF 10 ... Tissen ICM 10
A barbituric acid derivative that acts as a nonselective central nervous system depressant. It promotes binding to inhibitory gamma-aminobutyric acid subtype receptors, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
Approved
Investigational
Matched Mixtures name: … NORAL F SUPPOZİTUVAR 10 ADET ... PARANOX 120+15 MG 10 SUPOZİTUAR ... NORAL F FORTE SUPPOZİTUVAR 10 ADET …
Matched Products: … FENOBARBITAL 10 MG TABLETAS ... PHENOBARBITONE TABLET 10 mg ... FENOBARBITAL TABLETAS X 10 MG …
Prednisolone acetate is a prednisolone molecule bound to an acetate functional group by an ester bond. Prednisolone acetate was granted FDA approval in 1955.
Approved
Vet approved
Matched Mixtures name: … BLEPHAMIDE % 0,2 + % 10 GÖZ DAMLASI, SÜSPANSİYON, 5 ML …
Matched Products: … Prednifluid 10 mg/ml Augentropfensuspension …
Primidone is an anticonvulsant used to treat essential tremor as well as grand mal, psychomotor, and focal epileptic seizures. Primidone was developed by J Yule Bogue and H C Carrington in 1949. Primidone was granted FDA Approval on 8 March 1954.
Approved
Vet approved
Matched Description: … [A189522] Primidone was granted FDA Approval on 8 March 1954.[L11112] …
A benzodiazepine derivative used as an anticonvulsant and hypnotic.
Approved
Matched Products: … Nitrazepam-10 ... NITRAZEPAM AL 10 ... NITRAZEPAM-NEURAX 10 MG …
Oxiconazole is an antifungal agent that is commonly found in topical formulations. It is marketed under the brand names Oxistat and Oxistat, and is used in the treatment of various skin infections such as athlete's foot, jock itch and ringworm.
Approved
Matched Products: … OCERAL %1 KREM, 10 G ... OXEZOLE %1 KREM, 10 G ... ZOLEXOL % 1 KREM, 10 G …
Ustekinumab is a human immunoglobulin (Ig) G1 kappa monoclonal antibody directed against interleukin(IL)-12 and IL-23, which are cytokines that are involved in immune and inflammatory responses. It was generated via recombinant human IL-12 immunization of human Ig (hu-Ig) transgenic mice. It is a targeted biologic disease-modifying anti-rheumatic drug (bDMARDs) that...
Approved
Investigational
Umeclidinium is a long-acting muscarinic antagonist (LAMA) used as a maintenance treatment for symptoms of chronic obstructive pulmonary disease (COPD). COPD is a progressive obstructive lung disease characterized by shortness of breath, cough, sputum production, and chronically poor airflow with a forced expiratory volume in 1 second (FEV1) of less...
Approved
Oxazepam is an intermediate-acting, 3-hydroxybenzodiazepine used in the treatment of alcohol withdrawal and anxiety disorders. Oxazepam, like related 3-hydroxybenzodiazepine lorazepam, is considered less susceptible to pharmacokinetic variability based on patient-specific factors (e.g. age, liver disease) - this feature is advantageous as compared to other benzodiazepines, and is likely owing in...
Approved
Matched Products: … PRAXITEN 10 ... OXAZEPAM AL 10 ... OXAZEPAM STADA 10
Emapalumab, also known as NI-0501, is a fully human monoclonal antibody that targets interferon gamma. Emapalumab development was sponsored by NovImmune SA, further developed by Sobi and FDA approved on November 20, 2018.[A38676, L4840] The approval of emapalumab was followed by the designation of orphan drug, priority review and breakthrough...
Approved
Investigational
A vitamin-like antioxidant.
Approved
Investigational
Nutraceutical
Matched Mixtures name: … Medi-10
Matched Products: … NEWOXA 600 MG/50 ML ENJEKSİYONLUK ÇÖZELTİ , 10 FLAKON+10 UYGULAMA SETİ ... NİSİ-L 600 MG/50 ML ENJEKSİYONLUK ÇÖZELTİ , 10 FLAKON + 10 UYGULAMA SETİ ... INSULIPON 600 MG/50 ML ENJEKSIYONLUK ÇÖZELTI IÇEREN FLAKON, 10 FLAKON + 10 UYGULAMA SETI …
Multiple sclerosis, or MS, is a devastating inflammatory disease that often progresses and causes severe neurological, physical, and cognitive effects. Fingolimod is a sphingosine 1-phosphate receptor modulator for the treatment of relapsing-remitting multiple sclerosis. It was developed by Novartis and initially approved by the FDA in 2010. Fingolimod was also...
Approved
Investigational
Methyl salicylate (oil of wintergreen or wintergreen oil) is an organic ester naturally produced by many species of plants, particularly wintergreens. The compound was first extracted and isolated from plant species Gaultheria procumbens in 1843. It can be manufactured synthetically and it used as a fragrance, in foods, beverages, and...
Approved
Vet approved
Matched Mixtures name: … FRICSOL GEL 10-10% ... SADRÜD % 10 + % 15 JEL, 50 G ... BENGAY %10 + %15 MERHEM, 50 G …
Matched Products: … Methyl Salicylate 10% …
Carboplatin is an organoplatinum antineoplastic alkylating agent used in the treatment of advanced ovarian carcinoma. Early clinical studies of carboplatin were performed in 1982. Carboplatin was developed as an analog of cisplatin with reduced nephrotoxicity and vomiting.[A230463,A230523] Carboplatin was granted FDA approval on 3 March 1989.
Approved
Matched Products: … CARBOPLATINO 10 MG/ML ... CAREZ INJECTION 10 MG/ML ... KEMOCARB INJECTION 10 mg/ml …
Tocilizumab is a recombinant humanized monoclonal antibody IL-6 receptor inhibitor used to treat inflammatory and autoimmune conditions. It was first described in the literature in 2003 when Chugai, a subsidiary of Roche began developing IL-6 inhibiting monoclonal antibodies. Tocilizumab was granted FDA approval on 8 January 2010 to treat a...
Approved
Matched Description: … [A193281] Tocilizumab was granted FDA approval on 8 January 2010 to treat a number of inflammatory and …
Matched Products: … ACTEMRA 200 MG/10 ML IV INFUZYONLUK COZELTI KONSANTRESI İÇEREN FLAKON, 1 ADET ... ACTEMRA 200 MG/10 ML IV INFUZYONLUK COZELTI KONSANTRESI İÇEREN FLAKON, 4 ADET …
Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It has been classified differently according to its drug properties in which based on its chemical structure, gliclazide is considered a first-generation sulfonylurea due to the structural presence of a sulfonamide group able to release...
Approved
Matched Description: … 10 weeks of glucose control). ... glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels (reflective of the last 8- ... extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10
Imidazole derivative anesthetic and hypnotic with little effect on blood gases, ventilation, or the cardiovascular system. It has been proposed as an induction anesthetic.
Approved
Matched Products: … ETOMIDATE-LIPURO INJECTION 20 mg/10 ml ... HYPNOMIDATE 2 MG /10 ML AMPUL, 5 ADET ... ETOMIDE LIPURO 20MG/10ML IV ENJEKSIYONLUK EMULSIYON ICEREN AMPUL, 10 ADET …
A lignan found in podophyllin resin from the roots of podophyllum plants. It is a potent spindle poison, toxic if taken internally, and has been used as a cathartic. It is very irritating to skin and mucous membranes, has keratolytic actions, has been used to treat warts and keratoses, and...
Approved
Matched Iupac: … }]hexadeca-1,3(7),8-trien-12-one ... (10R,11R,15R,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15 …
Lacosamide is an antiepileptic drug used to treat seizures. As a chiral functionalized amino acid, it works by blocking slowly inactivating components of voltage-gated sodium currents. Lacosamide exhibits a stereoselective mode of interaction with sodium channels. Lacosamide was first approved by the European Commission in August 2008 and was later...
Approved
Matched Products: … Lacopat 10 mg/ml-Sirup ... BENVIDA 10 MG/ML JARABE ... ELEPSI 10 MG/ML ŞURUP,200 ML ŞIŞE …
Displaying drugs 1401 - 1425 of 3607 in total